Philip Gioia

Philip Gioia is a seasoned executive with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as President at Nordic Pharma and Venture Partner at Mianus Capital, Gioia also holds the position of Chief Executive Officer at Vinci Pharmaceuticals, Inc. since 2019. With a strong background in strategic management consulting through PharM&A Advisors, LLC, Gioia has played key roles in various organizations, including Chief Executive Officer at Eye Therapies, Chief Commercial Officer at Intrexon Corporation, and senior leadership positions at Bausch + Lomb, Glenmark Pharmaceuticals, and BARR Pharmaceuticals, Inc. Educational credentials include an MBA in Marketing from Sacred Heart University and a BS in Marketing from Montclair State University. Gioia has also contributed to numerous boards and advisory capacities, highlighting a commitment to innovation and growth in the ophthalmology field.